Works matching IS 00912700 AND DT 2024 AND VI 64 AND IP 1

Results: 16

The Vision for Expanding the Visibility of the Journal of Clinical Pharmacology: Meet the New Editor‐in‐Chief and the 3 New Associate Editors!
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 7, doi. 10.1002/jcph.2387
By:
- van den Anker, John N.;
- Arya, Vikram;
- Knibbe, Catherijne A. J.;
- Zhou, Honghui
Publication type:
Article
Inclusion of Obese Participants in Drug Development: Reflections on the Current Landscape and a Call for Action.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 13, doi. 10.1002/jcph.2377
By:
- Shen, Jinshan;
- Moore, Kenneth T.;
- Shukla, Suneet;
- Yeo, Karen Rowland;
- Venkatakrishnan, Karthik
Publication type:
Article
P‐Glycoprotein‐Mediated Interaction Is a Risk Factor for QT Prolongation in Concomitant Use of Antipsychotics and SSRIs as P‐Glycoprotein‐Mediated Inhibitors: Analysis of the Japanese Adverse Drug Event Report Database.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 118, doi. 10.1002/jcph.2343
By:
- Morishita, Hiroki;
- Perera, Liyanage Manosika Buddhini;
- Sunakawa, Hiroki;
- Kimura, Satsuki;
- Yoshida, Hitoshi;
- Ogihara, Takuo
Publication type:
Article
ACCP Position Statement on Hydration and Vitamin Infusion Clinics.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 10, doi. 10.1002/jcph.2364
By:
- Bonate, Peter L.;
- Prokopienko, Alexander J.;
- Gries, Jean‐Michel
Publication type:
Article
Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults: An Open‐Label, Phase 1 Study.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 67, doi. 10.1002/jcph.2347
By:
- Martin, David A.;
- Telliez, Jean‐Baptiste;
- Pleasic‐Williams, Susan;
- Zhang, Ying;
- Tierney, Brendan;
- Blatnik, Matthew;
- Gale, Jeremy D.;
- Banfield, Chris;
- Zhou, Yifan;
- Lejeune, Alexandre;
- Zwillich, Samuel H.;
- Stevens, Erin;
- Tiwari, Neeraj;
- Kieras, Elizabeth;
- Karanam, Ashwin
Publication type:
Article
Limited Sampling Strategies for Estimating Busulfan Area Under the Concentration–Time Curve: Based on Peak and Trough Concentrations in Saliva.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 58, doi. 10.1002/jcph.2345
By:
- Xu, Baohua;
- Zhou, Jianxing;
- Zheng, You;
- Xu, Ruichao;
- Liu, Qingxia;
- Li, Dandan;
- Liu, Maobai;
- Wu, Xuemei
Publication type:
Article
Physiologically Based Pharmacokinetic Modeling of the Drug–Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 80, doi. 10.1002/jcph.2348
By:
- Callegari, Ernesto;
- Tse, Susanna;
- Doran, Angela C.;
- Goosen, Theunis C.;
- Shaik, Naveed
Publication type:
Article
Missed Opportunities: Intravenous versus Oral Antibiotic De‐escalation for Treatment of Lower Extremity Osteoarticular Infections.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 137, doi. 10.1002/jcph.2342
By:
- Ruan, Haodi;
- Ryan, Keenan;
- Sosa, Nestor;
- Walraven, Carla
Publication type:
Article
The Influence of a Therapeutic Drug Monitoring Service on Vancomycin‐Associated Nephrotoxicity.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 19, doi. 10.1002/jcph.2363
By:
- Yang, Jennifer J.;
- Brett, Jonathan;
- Sordo, Anna;
- Reuter, Stephanie E.;
- Stocker, Sophie L.;
- Day, Richard O.;
- Roberts, Darren M.;
- Carland, Jane E.
Publication type:
Article
Immunogenicity of Cemiplimab: Low Incidence of Antidrug Antibodies and Cut‐Point Suitability Across Tumor Types.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 125, doi. 10.1002/jcph.2340
By:
- Valentine, Jenny L.;
- Dengler, Andrew;
- Zhao, An;
- Truong, Tiffany;
- McAfee, Sean;
- Hassanein, Mohamed;
- Irvin, Susan C.;
- Chen, Jihua;
- Meng, Xiao;
- Yan, Hong;
- Torri, Albert;
- Sumner, Giane;
- Andisik, Matthew D.;
- Paccaly, Anne;
- Partridge, Michael A.
Publication type:
Article
Drug‐Related Adverse Reactions in Pediatric Inflammatory Bowel Disease.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 103, doi. 10.1002/jcph.2339
By:
- Losa, Ana;
- Gomes, Rita;
- Mourão, Francisco Ribeiro;
- Cardoso, Sandra Soares;
- Vieira, Paula Manuel;
- Correia, Mário Rui;
- Silva, Helena Moreira;
- Silva, Gisela;
- Tavares, Marta;
- Silva, Ermelinda Santos;
- Lima, Rosa
Publication type:
Article
Pharmacokinetics and Pharmacodynamics of GalNAc‐Conjugated siRNAs.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 45, doi. 10.1002/jcph.2337
By:
- An, Guohua
Publication type:
Article
The Influence of Dexmedetomidine as an Adjuvant in Intrathecal Labor Analgesia: A Multicenter Study on Efficacy and Maternal Satisfaction.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 111, doi. 10.1002/jcph.2335
By:
- Lao, Chengyi;
- Zhu, Maoling;
- Yang, Yu;
- Lin, Xuejiang;
- Huang, Ruiping;
- Wei, Xiaofen;
- Wei, Xiaoyu
Publication type:
Article
Pharmacokinetic Modeling Using Real‐World Data to Optimize Unfractionated Heparin Dosing in Pediatric Patients on Extracorporeal Membrane Oxygenation and Evaluate Target Achievement–Clinical Outcomes Relationship.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 30, doi. 10.1002/jcph.2333
By:
- Salem, Ahmed M.;
- Smith, Trey;
- Wilkes, Jacob;
- Bailly, David K.;
- Heyrend, Caroline;
- Profsky, Michael;
- Yellepeddi, Venkata K.;
- Gopalakrishnan, Mathangi
Publication type:
Article
Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P‐Glycoprotein and Breast Cancer Resistance Protein Substrates.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 94, doi. 10.1002/jcph.2328
By:
- Luffer‐Atlas, Debra;
- Wilbraham, Darren;
- Posada, Maria M.;
- Landry, John;
- Tsai, Max;
- Pearlman, Eric M.
Publication type:
Article
Issue Information.
Published in:
Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 1, doi. 10.1002/jcph.2075
Publication type:
Article